Up­dat­ed da­ta from a tri­al of John­son & John­son’s ex­per­i­men­tal “pret­zel” showed that more than 80% of blad­der can­cer pa­tients who got the treat­ment saw their tu­mors melt away, build­ing ...

A group of Democratic and Republican senators introduced a bill on Thursday that calls for $275 million toward federal menopause research and awareness efforts over five years. The legislation would ...

The House Com­mit­tee on Over­sight will mark up a far-reach­ing bill on May 15 that, if passed, could force many US bio­phar­ma com­pa­nies to cut ties with WuXi and sev­er­al oth­er Chi­nese life ...

The Federal Trade Commission has extended its antitrust review of Novo Holdings’ $16.5 billion purchase of Catalent by potentially another 30 days as it requests additional information. Both the ...

(This sto­ry is from our new Health Tech newslet­ter. If you’d like to sign up, just click here.) The fight to dom­i­nate the mar­ket for weight loss shots has nev­er been hot­ter, but drug­mak­ers ...

AEON Bio­phar­ma said its bot­u­linum tox­in treat­ment can­di­date failed a Phase 2 mi­graine study at the planned in­ter­im analy­sis. The com­pa­ny ...

The Senate Finance Committee released a bipartisan draft legislation on Friday morning that would give Medicare bonuses to healthcare providers that help fight generic drug shortages. “It is ...

Despite the pharmaceutical industry’s heavy criticism of the Inflation Reduction Act, Johnson & Johnson, Pfizer and Bristol ...

AstraZeneca is working on moving its BTK inhibitor Calquence into earlier stages of mantle cell lymphoma, releasing what it ...

Newly appointed CEO Joe Papa outlined his vision for Emergent BioSolutions, which includes winding down two facilities and ...

Moderna’s shift to a more “restrained” posture was on full display Thursday morning during its first-quarter earnings update.

Welcome to Endpoints News’ manufacturing briefs, where we bring you essential news on new builds, collaborations, recalls and ...